Amphetamine Mixed Salts (Adderall) Tablet Shortage: February 2026 Update
The FDA reports ongoing supply disruptions for amphetamine mixed salts tablets, with several manufacturers experiencing limited availability or total stockouts through early 2026.
What’s in Shortage
The FDA has updated the status of the shortage involving Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, and Dextroamphetamine Sulfate Tablets. This medication, commonly known by the brand name Adderall, is a therapeutic agent used in the field of Psychiatry. The shortage affects various strengths of the tablet dosage form. While some presentations remain available, many manufacturers are reporting limited supplies or total unavailability.
Initial Posting Date: 10/12/2022
Last Updated: 02/04/2026
Which Manufacturers Are Affected
Supply status varies significantly by manufacturer and specific dosage strength:
-
Alvogen:
- Unavailable: 20mg (est. 2/20/2026), 30mg (est. 3/6/2026), and 5mg (est. 2/20/2026).
- Limited Availability: 15mg and 10mg (supporting contracted volume only).
- Contact: 844-842-8672 or CustomerService-US@alvogen.com
-
Elite Laboratories, Inc.:
- Limited Availability: 1.25mg, 7.5mg, 3.75mg, 1.875mg, 2.5mg, 3.125mg, and 5mg strengths (estimated 3-month duration).
- Contact: 888-852-6657
-
Teva Pharmaceuticals USA, Inc.:
- Available: Various strengths of Adderall and generic tablets (1.25mg, 2.5mg, 3.75mg, 1.875mg, 3.125mg).
- Limited Availability: 5mg (est. recovery Jan 2026), 7.5mg (est. recovery Feb 2026), and 3.75mg (est. recovery Feb 2026).
- Contact: 800-545-8800
-
Sandoz Inc.:
- Available: 1.25mg.
- Limited/Unavailable: 2.5mg, 5mg, and 7.5mg strengths are facing intermittent backorders in Q1 and early Q2 2026.
- Contact: 800-525-8747
-
SpecGx LLC:
- Available: 7.5mg, 5mg, 3.75mg, 1.25mg, 2.5mg, and 1.875mg strengths.
- Contact: 800-325-8888
-
Epic Pharma, LLC:
- Available: 2.5mg, 3.75mg, 5mg, and 1.25mg.
- Unavailable: 7.5mg (estimated availability in 2 weeks).
- Contact: (718) 276-8600 ext. 3
-
Lannett Company, Inc.:
- Available: 2.5mg, 1.875mg, 1.25mg, 7.5mg, 3.75mg, 3.125mg, and 5mg strengths.
- Contact: 844-834-0530
Why There’s a Shortage
The FDA source data lists the reason for this ongoing shortage as “Other.” No further specific details regarding manufacturing delays or demand increases were provided in the official database entry.
What Patients Should Do
If you are affected by this shortage, consider the following steps:
- Consult your pharmacist: They can check current stock for specific National Drug Codes (NDCs) and may know which manufacturers are currently delivering to their location.
- Contact your healthcare provider: Discuss the availability of different strengths or alternative treatment plans if your specific dosage is unavailable.
- Contact manufacturers: Use the contact information provided above to inquire about the most recent availability updates for your specific prescription.
Disclaimer: Patients should always consult with their healthcare provider or pharmacist regarding medication changes or treatment alternatives. Do not adjust your dosage without medical supervision.
Source
Data provided by the FDA Drug Shortage Database.
Source: FDA Official Notice
Related Articles
Dobutamine Hydrochloride Injection Shortage: Current Status and Manufacturer Availability
FDA · February 11, 2026
Morphine Sulfate Injection Shortage: Updates on Availability and Manufacturer Status
FDA · February 11, 2026
Clonazepam (Klonopin) Tablet Shortage: FDA Status and Manufacturer Availability Updates
FDA · February 11, 2026